12:45-12:55  Welcome by IAACI President 
Alon Hershko, Hadassah Medical Center, Ein Kerem, Jerusalem

 12:55-13:00  Greetings by AFI President
Jonathan Bernstein

 Session 1: Food Allergy 
Moderators: Ilan Dalal, Yael Levy

 13:00-13:30  Urticaria: Novel Therapeutic Strategies and Treatment Modalities that are Currently in the Pipeline
Ana Gimenez Arnau, Department of Dermatology, Hospital del Mar, Institut Mar d'Investigacions Mediques, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain

 13:30-13:42  Oral Immunotherapy (OIT) in Walnut and Hazelnut Co-Allergic Patients: ELISA Inhibition Studies to Direct Treatment Approach 
Yael Koren, Shamir Medical Center, Israel

 13:43-13:55  A Clinical Pathway for the Diagnosis of Sesame Allergy in Children
Diti Machnes-Maayani, Sheba Medical Center, Israel

 13:56-14:08  Food Desensitization: The Bnai Zion Medical Center Experience
Meital Almog, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion, Israel

 14:09-14:21  Oral Immunotherapy for Food Allergy in Adults
Na'ama Epstein-Rigbi, Shamir Medical Center, Israel

 14:22-14:34  Food Protein-Induced Allergic Proctocolitis in Breastfed Infants is not so Benign
Shira Benor, Tel Aviv Sourasky Medical Center, Israel 

 14:35-14:47  Food-Allergy Provoked Atypical Hidradenitis Suppurativa 
Eli Magen, Barzilai Medical Center, Ben Gurion University of the Negev, Israel 

 14:48-15:00  Treatment of Children with High Threshold Peanut Allergy
Soad Hajyahia, Sheba Medical Center, Israel

 15:01-15:13  Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy 
Liat Nachshon, Shamir Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Israel

 15:13-15:45  LIVE Q&A session

 Session 2: Drugs, Immunology and Covid 19 
Moderators: Alon Hershko, Nancy Agmon Levin

 15:45-16:15  Drug Allergy Assessments to Advance Care Quality and Patient Safety
Kimberly Blumenthal, Harvard Medical School, Boston, MA; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital; Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, USA

 16:15-16:45  Precision Medicine for Common Immunologic Problems: From Allergy to COVID
Joshua D Milner, Division of Allergy, Immunology and Rheumatology, Columbia University Medical Center, New York-Presbyterian Morgan Stanley Children's Hospital, New York, USA 

 16:46-16:58  Potential Protective Effect of Asthma from SARS-CoV-2 Infection 
Eli Magen, Barzilai Medical Center, Ben Gurion University of the Negev, Israel

 16:59-17:11  Food Allergic Reactions During the COVID-19 Home-Confinement
Nadira Musallam, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion, Israel

 17:12-17:24  Racial Disparity in Covid-19 Mortality Rates - A Plausible Explanation  
Yuval Tal, Hadassah, Hebrew University Medical Center, Israel

 17:24-18:00  LIVE Q&A session

18:00-18:30  IAACI General Assembly

לינק לצפייה באסיפה (for Association members only) 

 Session 3: Immune Deficiency 
Moderators: David Hagin, Amit Nahum

 08:30-08:42  Inherited SLP76 Deficiency in Humans Causes Severe Combined Immunodeficiency, Neutrophil and Platelets Defects
Raz Somech, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel

 08:43-08:55  A Novel Zeta-Associated Protein 70 Homozygous Mutation Causing Severe Combined Immunodeficiency Presenting as Neonatal Autoimmune Hemolytic Anemia 
Arnon Broides, Soroka University Medical Center, Ben-Gurion University of the Negev, Israel

 08:56-09:08  Hyper IgE Syndrome – Not only a STAT3 Deficiency 
Idit Lachover, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Israel

 09:09-09:21  Combined Immunodeficiency (CVID and CD4 lymphopenia) Withhold a High Risk of Malignancy Among Adults with Primary Immune Deficiency
Ronen Shavit, Sheba Medical Center, Israel 

 09:21-09:33  Chronic Demodicosis and Polyautoimmunity: Remember STAT1 Gain of Function
Oded Shamriz, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Israel

 09:34-09:46  Minor clinical impact of COVID 19 pandemic on patients with primary immunodeficiency (PID) in Israel
Nufar Marcus, Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Israel

 09:47-10:07  Host Microbiome Interactions In Health and Disease
Eran Elinav, Department of Immunology, Weizmann Institute of Science, Israel, Division of Microbiome and Cancer, DKFZ, Heidelberg, Germany

 10:08-10:35  LIVE Q&A session

 Session 4: Highlights in Allergy and Immunology 
Moderators: Avi Beigelman, Yuval Tal

 10:35-10:47  Autoimmune Inner Ear Disease Among Patients with Selective IgA Deficiency 
Eli Magen, Barzilai University Medical Center, Ben-Gurion University of the Negev, Israel

 10:48-11:00  The Role of Ethnicity Among Israeli Patients with APS
Stanley Niznik, Shamir Medical Center, Israel

 11:01-11:13  Allergy is Written in the Gene 
Carmi Geller-Bernstein, Sheba Medical Center, Israel   

 11:14-11:26  Does Allergy Immunotherapy Provide Protection (Desensitization) or Cure (Tolerance)? 
Menachem Rottem, Emek Medical Center, Rappaport faculty of Medicine, Technion, Israel

 11:27-11:39  Iodinated Contrast Media Allergy Revisited
Alon Hershko, Hadassah Medical Center, Israel

 11:40-12:15  LIVE Q&A session

Closing Remarks